Title | Type | SJR | H index | Total Docs. (2000) | Total Docs. (3years) | Total Refs. (2000) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2000) | %Female (2000) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Journal of Biopharmaceutical Statistics | journal | 1.190 Q1 | 56 | 38 | 132 | 618 | 107 | 127 | 0.64 | 16.26 | 18.18 | |
52 | Microbial Drug Resistance | journal | 1.733 Q1 | 78 | 41 | 131 | 1263 | 487 | 131 | 3.73 | 30.80 | 42.01 | |
53 | Addiction Biology | journal | 0.459 Q2 | 93 | 48 | 130 | 2182 | 156 | 127 | 0.93 | 45.46 | 27.67 | |
54 | Drug and Chemical Toxicology | journal | 0.238 Q3 | 54 | 44 | 125 | 1220 | 84 | 124 | 0.66 | 27.73 | 30.40 | |
55 | Metal-Based Drugs | journal | 0.320 Q3 | 40 | 47 | 122 | 1291 | 104 | 121 | 0.85 | 27.47 | 33.86 | |
56 | Journal of Immunotherapy | journal | 1.097 Q1 | 106 | 48 | 120 | 596 | 354 | 117 | 2.59 | 12.42 | 32.28 | |
57 | Journal of Biomolecular Screening | journal | 0.754 Q1 | 86 | 49 | 111 | 721 | 215 | 99 | 2.22 | 14.71 | 26.47 | |
58 | Neuropsychopharmacology Reports | journal | 22 | 40 | 109 | 1182 | 25 | 108 | 0.21 | 29.55 | 8.16 | ||
59 | Drug Resistance Updates | journal | 0.690 Q1 | 132 | 48 | 107 | 2692 | 188 | 99 | 1.76 | 56.08 | 22.35 | |
60 | Journal of Pharmacokinetics and Pharmacodynamics | journal | 0.350 Q2 | 70 | 0 | 106 | 0 | 115 | 100 | 0.99 | 0.00 | 0.00 | |
61 | CNS Drug Reviews | journal | 0.282 Q3 | 64 | 23 | 96 | 1454 | 84 | 96 | 0.68 | 63.22 | 14.52 | |
62 | Journal of Herbs, Spices and Medicinal Plants | journal | 0.199 Q3 | 34 | 50 | 80 | 975 | 31 | 79 | 0.31 | 19.50 | 36.36 | |
63 | Cardiovascular Drug Reviews | journal | 0.322 Q3 | 54 | 26 | 74 | 888 | 69 | 74 | 0.65 | 34.15 | 17.14 | |
64 | Medicinal Research Reviews | journal | 1.338 Q1 | 150 | 22 | 71 | 2038 | 266 | 70 | 3.35 | 92.64 | 20.83 | |
65 | Research Communications in Pharmacology and Toxicology | journal | 0.124 Q4 | 8 | 10 | 61 | 351 | 8 | 61 | 0.05 | 35.10 | 25.00 | |
66 | Clinical Research and Regulatory Affairs | journal | 0.117 Q4 | 18 | 17 | 60 | 310 | 7 | 57 | 0.16 | 18.24 | 11.11 | |
67 | Annual Review of Pharmacology and Toxicology | journal | 11.736 Q1 | 224 | 27 | 58 | 653 | 1393 | 58 | 20.47 | 24.19 | 20.75 | |
68 | Pharmacological Reviews | journal | 11.816 Q1 | 254 | 23 | 57 | 7959 | 1370 | 57 | 25.67 | 346.04 | 17.81 | |
69 | Pharmacopeial Forum (discontinued) | journal | 0.229 Q3 | 20 | 12 | 50 | 175 | 12 | 50 | 0.24 | 14.58 | 23.81 | |
70 | Clin-Alert | journal | 0.100 Q4 | 0 | 0 | 47 | 0 | 0 | 47 | 0.00 | 0.00 | 0.00 | |
71 | Journal of Immunotherapy | journal | 47 | 55 | 42 | 1863 | 178 | 42 | 5.83 | 33.87 | 28.23 | ||
72 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.519 Q1 | 82 | 14 | 36 | 2827 | 202 | 36 | 4.12 | 201.93 | 25.64 | |
73 | Journal of Infectious Disease Pharmacotherapy | journal | 0.141 Q3 | 6 | 0 | 29 | 0 | 6 | 28 | 0.21 | 0.00 | 0.00 | |
74 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.120 Q4 | 29 | 0 | 24 | 0 | 4 | 22 | 0.17 | 0.00 | 0.00 | |
75 | Adverse Drug Reaction Bulletin | journal | 0.163 Q3 | 8 | 6 | 18 | 175 | 10 | 18 | 0.58 | 29.17 | 11.11 | |
76 | Advances in Drug Research | journal | 0.604 Q2 | 11 | 0 | 9 | 0 | 23 | 9 | 0.00 | 0.00 | 0.00 | |
77 | Anti-Cancer Drug Design | journal | 0.910 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
78 | Molecular Therapy | journal | 209 | 170 | 0 | 5838 | 0 | 0 | 0.00 | 34.34 | 28.47 | ||
79 | National Toxicology Program technical report series | journal | 22 | 1 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®